STANGER KENT W 4

4 · MERIT MEDICAL SYSTEMS INC · Filed Dec 19, 2017

Form 4

Period: 2017-12-15

DirectorChief Financial Officer

Transactions

Exercise/Conversion
Non-qualified stock options (right to buy)
2017-12-15−9,082→ 42,000 total
Exercise: $13.75From: 2012-08-11Exp: 2018-08-11→ Common Stock (9,082 underlying)
Sale
Common Stock, No Par Value
2017-12-15$44.90/sh−9,082$407,782→ 411,534 total
Exercise/Conversion
Common Stock, No Par Value
2017-12-15$13.75/sh+9,082$124,878→ 420,616 total

Holdings

Common Stock, No Par Value
4,271
Non-qualified stock options (right to buy)
Exercise: $19.72From: 2017-05-02Exp: 2023-05-02→ Common Stock (9,375 underlying)
9,375
Common Stock, No Par Value
(indirect: By 401(k))
42,277
Common Stock, No Par Value
(indirect: Family Limited Liability Company)
29,524
Non-qualified stock options (right to buy)
Exercise: $12.06From: 2015-10-04Exp: 2021-10-04→ Common Stock (2,000 underlying)
2,000
Non-qualified stock options (right to buy)
Exercise: $18.80From: 2017-05-26Exp: 2023-05-26→ Common Stock (25,000 underlying)
25,000
Non-qualified stock options (right to buy)
Exercise: $34.40From: 2018-05-24Exp: 2024-05-24→ Common Stock (25,000 underlying)
25,000

Footnotes (9)

[F1]Represents plan holdings as of 12/15/2017.
[F2]Employee stock purchase plan holdings as of 12/15/2017.
[F3]This report shall not be deemed an admission that the reporting person is the beneficial owner of the securities held by K.W.S. Properties LC.
[F4]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.50 to $45.35, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F5]Becomes exercisable in equal annual installments of 20% commencing on 08/11/2012.
[F6]Becomes exercisable in equal annual installments of 20% commencing on 10/04/2015.
[F7]Becomes exercisable in equal annual installments of 20% commencing on 05/02/2017.
[F8]Becomes exercisable in equal annual installments of 20% commencing on 05/26/2017.
[F9]Becomes exercisable in equal annual installments of 20% commencing on 05/24/2018.

Documents

1 file